• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Corcept Therapeutics Incorporated - Common Stock (NQ:CORT)

32.15 -0.24 (-0.74%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Corcept Therapeutics Incorporated - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
News headline image
CORT Investors Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit with the Schall Law Firm
March 13, 2026
From Schall Law
Via GlobeNewswire
News headline image
CORCEPT THERAPEUTICS INCORPORATED (CORT) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Corcept Therapeutics Incorporated Investors of Upcoming Deadline
March 12, 2026
From Bernstein Liebhard LLP
Via GlobeNewswire
News headline image
Corcept Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Corcept Therapeutics Incorporated - CORT
March 11, 2026
From SkyMedia, LLC
Via GlobeNewswire
News headline image
1 High-Flying Stock with Impressive Fundamentals and 2 We Avoid
March 11, 2026
Expensive stocks typically earn their valuations through superior growth rates that other companies simply can’t match. The flip side though is that these lo... 
Via StockStory
Topics Credit Cards
News headline image
Corcept Therapeutics Incorporated Securities Fraud Class Action Result of FDA Approval Issues and 50% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
March 10, 2026
From Kahn Swick & Foti, LLC
Via GlobeNewswire
News headline image
Bragar Eagel & Squire, P.C. Urges Navan and Corcept Investors with Large Losses to Contact the Firm Before the Upcoming Lead Plaintiff Deadlines
March 10, 2026
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
REMINDER: Corcept Therapeutics Incorporated Investors With Significant Losses Must Act By April 21, 2026
March 10, 2026
From Kirby McInerney LLP
Via Business Wire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Corcept Therapeutics Incorporated of Class Action Lawsuit and Upcoming Deadlines – CORT
March 10, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
CORT Investors Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit with the Schall Law Firm
March 10, 2026
From Schall Law
Via GlobeNewswire
News headline image
Important Notice to Long-Term Shareholders of Boston Scientific Corporation (NYSE: BSX): Corcept Therapeutics, Inc. (NASDAQ: CORT); Nektar Therapeutics (NASDAQ: NKTR): and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office Investigates Claims
March 10, 2026
From Grabar Law Office
Via GlobeNewswire
News headline image
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Corcept Therapeutics Incorporated (CORT)
March 10, 2026
From Bernstein Liebhard LLP
Via GlobeNewswire
News headline image
Kaplan Fox Alerts Investors to a Deadline for a Securities Fraud Class Action Lawsuit against Corcept Therapeutics, Inc. (NASDAQ: CORT) - Contact Kaplan Fox Before April 21, 2026
March 08, 2026
NEW YORK, NY - March 8, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Corcept Therapeutics, Inc. (“Corcept” or the “Company”) (NASDAQ:... 
Via TheNewswire.com
Topics Fraud Lawsuit
News headline image
Kaplan Fox Alerts Investors to a Deadline for a Securities Fraud Class Action Lawsuit against Corcept Therapeutics, Inc. (NASDAQ: CORT) - Contact Kaplan Fox Before April 21, 2026
March 08, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
News headline image
CORT ALERT: Deadline in Securities Class Action Lawsuit against Corcept Therapeutics, Inc. (NASDAQ: CORT) is April 21, 2026 - Contact Kaplan Fox
March 07, 2026
NEW YORK, NY - March 7, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Corcept Therapeutics, Inc. (“Corcept” or the “Company”) (NASDAQ:... 
Via TheNewswire.com
Topics Lawsuit
News headline image
CORT ALERT: Deadline in Securities Class Action Lawsuit against Corcept Therapeutics, Inc. (NASDAQ: CORT) is April 21, 2026 - Contact Kaplan Fox
March 07, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
CORCEPT THERAPEUTICS CLASS ACTION DEADLINE: Kaplan Fox Encourages Corcept Therapeutics, Inc. (NASDAQ: CORT) Investors to Contact the Firm Before the Lead Plaintiff Deadline on April 21, 2026
March 06, 2026
NEW YORK, NY - March 6, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Corcept Therapeutics, Inc. (“Corcept” or the “Company”) (NASDAQ:... 
Via TheNewswire.com
Topics Lawsuit
News headline image
CORCEPT THERAPEUTICS CLASS ACTION DEADLINE: Kaplan Fox Encourages Corcept Therapeutics, Inc. (NASDAQ: CORT) Investors to Contact the Firm Before the Lead Plaintiff Deadline on April 21, 2026
March 06, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
CORT Investors Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit with the Schall Law Firm
March 06, 2026
From Schall Law
Via GlobeNewswire
News headline image
CORT DEADLINE: Kaplan Fox Alerts Corcept Therapeutics, Inc. (CORT) Investors to a Securities Class Action Deadline on April 21, 2026
March 06, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
CORT DEADLINE: Kaplan Fox Alerts Corcept Therapeutics, Inc. (CORT) Investors to a Securities Class Action Deadline on April 21, 2026
March 06, 2026
NEW YORK, NY - March 6, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Corcept Therapeutics, Inc. (“Corcept” or the “Company”) (NASDAQ:... 
Via TheNewswire.com
Topics Lawsuit
News headline image
Important Notice to Long-Term Shareholders of Corcept Therapeutics, Inc. (NASDAQ: CORT); Kyndryl Holdings (NYSE: KD); Molina Healthcare, Inc. (NYSE: MOH); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office Investigates Claims on Your
March 05, 2026
From Grabar Law Office
Via GlobeNewswire
News headline image
CORCEPT THERAPEUTICS INCORPORATED (CORT) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Corcept Therapeutics Incorporated Investors of Upcoming Deadline
March 05, 2026
From Bernstein Liebhard LLP
Via GlobeNewswire
News headline image
Corcept Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Corcept Therapeutics Incorporated - CORT
March 04, 2026
From SkyMedia, LLC
Via GlobeNewswire
News headline image
Law Offices of Frank R. Cruz Encourages Corcept Therapeutics Incorporated (CORT) Shareholders To Inquire About Securities Fraud Class Action
March 04, 2026
From Law Offices of Frank R. Cruz
Via Business Wire
News headline image
Corcept Therapeutics Incorporated Securities Fraud Class Action Result of FDA Approval Issues and 50% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
March 03, 2026
From Kahn Swick & Foti, LLC
Via GlobeNewswire
News headline image
Important Notice to Long-Term Shareholders of Corcept Therapeutics, Inc. (NASDAQ: CORT); Integer Holdings Corp. (NYSE: ITGR); Kyndryl Holdings (NYSE: KD); and Molina Healthcare, Inc. (NYSE: MOH): Grabar Law Office Investigates Claims on Your Behalf
March 03, 2026
From Grabar Law Office
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Corcept Therapeutics Incorporated of Class Action Lawsuit and Upcoming Deadlines – CORT
March 03, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
Deadline Alert: Corcept Therapeutics Incorporated (CORT) Shareholders Who Lost Money Urged to Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
March 03, 2026
From Glancy Prongay Wolke & Rotter LLP
Via Business Wire
News headline image
CORT Investors Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit with the Schall Law Firm
March 03, 2026
From Schall Law
Via GlobeNewswire
News headline image
Investors of Corcept Therapeutics, Inc. (CORT) Seeking Recovery - Contact Kaplan Fox Before Deadline on April 21, 2026
March 03, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap